Revenue Cycle Management M&A Advisory

Comprehensive Revenue Cycle Management Support and Solutions to Improve Operations, Cash Flow and Patient Management.
Contact Us

Growth in reimbursement challenges, resource requirements and outsourcing are increasing providers’ demand for sophisticated Revenue Cycle Management (RCM) solutions. Kroll has successfully advised privately owned, sponsor-backed businesses and other middle-market companies on their RCM solutions. Our team provides consistent, independent and objective M&A advisory support, resulting in strong outcomes for shareholders and management.

Supporting Client Objectives:
Kroll’s global transaction team consists of senior bankers with deep expertise in the RCM sector. The transaction team strives to maintain an active dialogue with key financial investors/buyers and are thought leaders in the industry. Clients rely on Kroll’s extensive RCM experience. Our differentiators include:

  • Trusted transaction experience with RCM businesses, including several recent closings in the sector
  • Valuable sales process for buyers in the strategic and financial field
  • Collaborative relationship between Kroll bankers and management team to develop detailed financial projections and company positioning that delivers a long-lasting message to the marketplace to achieve a better outcome for shareholders
  • Active dialogue with a variety of buyers from the strategic, private equity and family office regions active in the healthcare services sector
  • Dedicated Financial Sponsors Group that support mutually long-term relationships with leading private equity firms
  • Recent transactions in the RCM sector that provides real-time market feedback on RCM industry trends, buyers activity, valuation metrics, etc.

Kroll is a Leader in Corporate Finance and M&A Advisory

Kroll is the #5 ranked U.S middle-market advisor over the past 10 years, with over 600 firm wide M&A transactions completed in that time.1

Why Kroll

  • Senior-level attention and involvement at each stage of the transaction process
  • One of the broadest financial sponsor and family office coverage effort in the middle market
  • Breadth of in-house corporate finance and financial advisory services, which significantly enhance our Industrial M&A processes and outcomes for our clients
  • Healthcare is one of five core industry verticals for Kroll’s Corporate Finance Practice
  • We are the finical advisor and exclusive placement agent for national and global healthcare technology companies that provide services to healthcare providers, healthcare clients, and others

1 Refinitiv Data (U.S. deals $10M < $170M, including deals without a disclosed value). Full years 2012 through 2021.



Valuation of businesses, assets and alternative investments for financial reporting, tax and other purposes.

Cyber Risk

Incident response, digital forensics, breach notification, managed detection services, penetration testing, cyber assessments and advisory.

Compliance and Regulation

End-to-end governance, advisory and monitorship solutions to detect, mitigate and remediate security, legal, compliance and regulatory risk.

Corporate Finance and Restructuring

M&A advisory, restructuring and insolvency, debt advisory, strategic alternatives, transaction diligence and independent financial opinions.

Investigations and Disputes

World-wide expert services and tech-enabled advisory through all stages of diligence, forensic investigation, litigation, disputes and testimony.

Digital Technology Solutions

Enriching our professional services, our integrated software platform helps clients discover, quantify and manage risk in the corporate and private capital market ecosystem.

Business Services

Expert provider of complex administrative solutions for capital events globally. Our services include claims and noticing administration, debt restructuring and liability management services, agency and trustee services and more.

Environmental, Social and Governance

Advisory and technology solutions, including policies and procedures, screening and due diligence, disclosures and reporting and investigations, value creation, and monitoring.